Alniche Lifesciences, one of the leading and fastest growing pharma companies of India is celebrating National Nutrition Week. This week-long initiative is aimed at spreading awareness about the importance of nutrition for the human body and well-being through a series of activities planned at various hospitals.
Mr. Girish Arora, Founder & MD
Healthy people make a healthy nation – “Healthy Rahega India, Tabhi Toh Bimariyon se Bachega India”. The importance of nutrition for health has an impact on development, productivity, economic growth and ultimately National Development.
Mr. Girish Arora, Founder & MD
Commenting on the week-long celebrations, Mr. Girish Arora, Founder & MD, said, “I believe it is imperative to educate people about the significance of including the proper nutrients in their daily diets. It is our endeavour to empower customers with an exclusive range of nutritional, and Immunity booster therapies that play a key role in fostering a Wellness Quotient. We aim to emphasize the critical role that nutrition plays in the current environment, which will directly affect the productivity and social and economic development of the nation.”
About Alniche Lifesciences
Alniche has 800+ employees with 5000+ distribution points both for prescription and OTX brands, covering 70,000 doctors and 40,000 hospitals. Alniche has emerged as a fierce competitor in the nephrology and critical care segment and is continuing the success story in newly expanded therapy segments. With a strong product portfolio, both domestically manufactured and licensed from global pharma, Alniche fulfills the unmet needs of patients in the areas of nephrology, critical Care, gastroenterology, dermatology, neuropsychiatry and cardiac diabetes care.
The company’s vision is to bring medicines and market across a wide range of therapies, as well as to become the chosen partner of global lifesciences enterprises and mission is to offer the best quality medicines to the maximum number of people for which Alniche is maximizing the business potential of both domestic and international partners. The companys plan is to combine marketing strategy with a niche portfolio to approach the targeted doctors. This includes programmes such as CMEs, symposia, teleconsultations, disease information and management, advocacy development, and the most recent therapeutic regimen – book release, practice support, and decision enhancement tools, to name a few.
